DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,515,000 | +48.7% | 40,584 | +1.8% | 0.00% | 0.0% |
| Q1 2021 | $1,019,000 | +365.3% | 39,865 | +301.2% | 0.00% | – |
| Q4 2020 | $219,000 | -40.2% | 9,937 | -40.2% | 0.00% | – |
| Q4 2019 | $366,000 | -81.8% | 16,618 | -88.1% | 0.00% | -100.0% |
| Q3 2019 | $2,006,000 | -34.5% | 139,683 | -28.2% | 0.00% | -33.3% |
| Q2 2019 | $3,064,000 | – | 194,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
| Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
| RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
| Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
| DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
| Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
| Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
| Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
| AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
| Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |